EHMTI-0048. Epigenetic changes in a rat model of migraine with aura by unknown
MEETING ABSTRACT Open Access
EHMTI-0048. Epigenetic changes in a rat model of
migraine with aura
M Vila-Pueyo1*, N Fernández-Castillo2, B Cormand2, P Pozo-Rosich3, A Macaya1
From 4th European Headache and Migraine Trust International Congress: EHMTIC 2014
Copenhagen, Denmark. 18-21 September 2014
Introduction
Migraine with aura (MA) is a subtype of migraine charac-
terized by reversible neurological disturbances preceding
headache. Epigenetic mechanisms are postulated to med-
iate migraine susceptibility. MA neurophysiological corre-
late is cortical spreading depression (CSD), a wave of
neuronal depolarization and depression that is suppressed
by chronic administration of the migraine preventive
drugs valproate and topiramate.
Aims
Using a CSD rat model, we investigated if valproate and
topiramate lower the susceptibility to develop CSD by
inducing changes in brain DNA methylation.
Methods
Adult male Sprague-Dawley rats were treated with
valproate, topiramate or saline for 4 weeks. CSDs were
KCl-induced for 1 hour. Cortices were removed and DNA
was extracted to perform MBD-based genome-wide
methylation sequencing. Results were analyzed by MED-
IPS software to obtain differentially methylated regions
(DMRs). Genes containing DMRs were analyzed for GO
and KEGG pathways enrichment and gene networks were
constructed using IPA software.
Results
Both treatments, as expected, reduced CSD intensity. Both
drugs induced differential methylation (DM) of genes
belonging to “synapse activity” pathways including
Rimbp2 and Grip1. Treatment with valproate was asso-
ciated with DM of ion channel encoding-genes such as
Asic2 and Kcnd2. CSD, in turn, promoted DM of genes
involved in axon growth (Cdh13), modulation of pain
(Mrgprx3) or neuronal proliferation (Mapk10).
Conclusions
These results confirm that valproate and topiramate
protect against CSD in the rat and that this is associated
with changes in brain DNA methylation. Further analyses
are required to determine the potential of the identified
targets in determining susceptibility to human migraine.
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